Endotoxins are integral components of the outer cell membrane of gram-negative bacteria such as Escherichia coli. Structurally, endotoxin consists of a variable O-antigen, a core oligosaccharide, and a highly conserved lipid A moiety. The lipid A portion is the primary driver of biological toxicity, capable of triggering massive innate immune responses (e.g., chemokine and cytokine release, inflammation, and potentially fatal septic shock).
During the lysis of bacterial cells in recombinant protein production, these molecules inevitably contaminate the preparation. Endotoxin removal is the process of sequestering these pyrogens from biological solutions. Effective chromatographic removal utilizes ligands that compete the protein-LPS interactions. Our Endotoxin Removal Chromatographic Column helps you obtain ultra-pure recombinant proteins and pDNA through proprietary high-affinity ligand chemistry and advanced monolithic matrix technology to ensure the final product is safe for therapeutic use.
While traditional methods like ultrafiltration or ion-exchange chromatography often result in significant protein loss or insufficient clearance. Our endotoxin removal chromatographic column is engineered with specific technical features to address the unique challenges of pyrogen clearance. The columns are designed with specialized ligand chemistry to achieve deep depletion without sacrificing your target molecule.
We utilize specialized ligands (e.g., synthetic biomimetics and poly-cationic networks) that specifically target the Lipid A region of endotoxin.
Our monolithic poly (glycidyl methacrylate) (PGMA) matrix provides large pores for rapid mass transfer and high adsorption kinetics.
The technology is optimized to work alongside chelating agents, breaking down large LPS complexes into subunits for easier capture.
The columns are stable across a wide pH range (3.0-12.0) and resistant to standard cleaning-in-place protocols.
The hydrophilic matrix reduces hydrophobic stickiness and ensures the protein recoveries (>90%).
The workflow for an endotoxin removal chromatographic column is a multi-stage process designed to disrupt complex molecular interactions and isolate pure bioproducts. At Creative Biolabs, our standardized workflow is optimized for both benchtop and pilot-scale production.
Creative Biolabs offers a suite of Endotoxin Removal Chromatographic Column products designed to meet the rigorous demands of modern biopharmaceutical purification. Our portfolio spans from initial laboratory discovery to full-scale industrial manufacturing, ensuring consistency in pyrogen clearance across all development phases.
Designed for rapid, small-scale (mg) clearance, these columns are ideal for research and discovery settings.
Available in standardized 1 mL and 5 mL formats, and custom 1 L to 5 L volumes for pilot and production scales. These columns are fully compatible with automated systems like the ÄKTA explorer.
Bulk media for large-scale industrial applications requiring high-flow performance and chemical robustness. Our proprietary resin features advanced ligand chemistry which specifically targets endotoxins.
Optimized for the removal of endotoxins from plasmid DNA vaccines, utilizing pore sizes tailored for large nucleic acid base exposure.
Creative Biolabs provides the biopharmaceutical industry with the most advanced solutions for endotoxin removal. Our pyrogen clearance technology ensures your biotherapeutics are safe, pure, and ready for the clinic. Contact us for detailed product specifications and custom quotes.
With proper regeneration, the columns can be reused for up to 15 cycles. We recommend monitoring the peak asymmetry and HETP to ensure continued column efficiency.
We offer specific matrices designed for large molecules like plasmid DNA, ensuring high selectivity over RNA and host cell proteins while achieving >90% reduction in endotoxin levels.
A linear flow rate of 60-100 cm/h is generally ideal for capture steps to ensure adequate residence time for ligand-LPS interaction.
Yes, Creative Biolabs supplies resin in bulk quantities, supported by full regulatory documentation to facilitate your transition to clinical manufacturing.
Reference
Contact Us
